140 related articles for article (PubMed ID: 24857045)
1. Prognostic factors in malignant ovarian germ cell tumours (The Surveillance, Epidemiology and End Results experience 1978-2010).
Solheim O; Gershenson DM; Tropé CG; Rokkones E; Sun CC; Weedon-Fekjaer H; Fosså SD
Eur J Cancer; 2014 Jul; 50(11):1942-50. PubMed ID: 24857045
[TBL] [Abstract][Full Text] [Related]
2. Malignant ovarian germ cell tumors: presentation, survival and second cancer in a population based Norwegian cohort (1953-2009).
Solheim O; Kærn J; Tropé CG; Rokkones E; Dahl AA; Nesland JM; Fosså SD
Gynecol Oncol; 2013 Nov; 131(2):330-5. PubMed ID: 24001518
[TBL] [Abstract][Full Text] [Related]
3. Incidence and outcomes of malignant ovarian germ cell tumors in Korea, 1999-2017.
Park M; Lim J; Lee JA; Park HJ; Park BK; Lim MC; Park SY; Won YJ
Gynecol Oncol; 2021 Oct; 163(1):79-84. PubMed ID: 34392955
[TBL] [Abstract][Full Text] [Related]
4. The individualized significance of lymphadenectomy across all age groups and histologies in malignant ovarian germ cell tumors.
Wang J; Chen R; Li J; Lu X
Arch Gynecol Obstet; 2020 Dec; 302(6):1441-1450. PubMed ID: 32888090
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological Features, Prognostic Factors, Survival Trends, and Treatment of Malignant Ovarian Germ Cell Tumors: A SEER Database Analysis.
Guo H; Chen H; Wang W; Chen L
Oncol Res Treat; 2021; 44(4):145-153. PubMed ID: 33706324
[TBL] [Abstract][Full Text] [Related]
6. Socioeconomic disparities affect survival in malignant ovarian germ cell tumors in AYA population.
Bownes LV; Stafman LL; Maizlin II; Dellinger M; Gow KW; Goldin AB; Goldfarb M; Langer M; Raval MV; Doski JJ; Nuchtern JG; Vasudevan SA; Beierle EA
J Surg Res; 2018 Feb; 222():180-186.e3. PubMed ID: 28988685
[TBL] [Abstract][Full Text] [Related]
7. Trends in the surgical management of malignant ovarian germcell tumors.
Nasioudis D; Mastroyannis SA; Latif NA; Ko EM
Gynecol Oncol; 2020 Apr; 157(1):89-93. PubMed ID: 32008791
[TBL] [Abstract][Full Text] [Related]
8. [Clinical analysis of 15 cases of malignant ovarian germ cell tumors with lung metastasis].
Liu Y; Ren T; Feng FZ; Wan XR; Shen K; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):40-4. PubMed ID: 22455692
[TBL] [Abstract][Full Text] [Related]
9. Is carboplatin-based chemotherapy as effective as cisplatin-based chemotherapy in the treatment of advanced-stage dysgerminoma in children, adolescents and young adults?
Shah R; Xia C; Krailo M; Amatruda JF; Arul SG; Billmire DF; Brady WE; Covens A; Gershenson DM; Hale JP; Hurteau J; Murray MJ; Nicholson JC; Olson TA; Pashankar F; Rodriguez-Galindo C; Shaikh F; Stark D; Frazier AL; Stoneham S
Gynecol Oncol; 2018 Aug; 150(2):253-260. PubMed ID: 29884437
[TBL] [Abstract][Full Text] [Related]
10. The prevalence and prognostic impact of lymph node metastasis in malignant germ cell tumors of the ovary.
Kumar S; Shah JP; Bryant CS; Imudia AN; Cote ML; Ali-Fehmi R; Malone JM; Morris RT
Gynecol Oncol; 2008 Aug; 110(2):125-32. PubMed ID: 18571705
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of laterality in malignant ovarian germ cell tumors.
Mahdi H; Kumar S; Seward S; Semaan A; Batchu R; Lockhart D; Tamimi H; Munkarah AR
Int J Gynecol Cancer; 2011 Feb; 21(2):257-62. PubMed ID: 21475076
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological Features and Survival Trends of Non-Epithelial Ovarian Cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database.
Zhang C; Xi X
Oncol Res Treat; 2023; 46(11):476-492. PubMed ID: 37857263
[TBL] [Abstract][Full Text] [Related]
13. [Malignant ovarian germ cell tumors--clinical characteristics and analysis of outcomes].
Miedzińska-Maciejewska M; Bobkiewicz P; Gawrychowski K
Ginekol Pol; 2011 May; 82(5):338-43. PubMed ID: 21851031
[TBL] [Abstract][Full Text] [Related]
14. Nomograms to predict the prognosis in malignant ovarian germ cell tumors: a large cohort study.
Song Z; Wang Y; Zhou Y; Zhang D
BMC Cancer; 2022 Mar; 22(1):257. PubMed ID: 35272629
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Impact of Lymphadenectomy in Different Stages of Malignant Germ Cell Tumor of the Ovary Based on Propensity Score Matching.
Chen Y; Ning Y; Zhang Q; Xie Y
Comb Chem High Throughput Screen; 2018; 21(9):652-661. PubMed ID: 30569854
[TBL] [Abstract][Full Text] [Related]
16. Incidence and survival rates for female malignant germ cell tumors.
Smith HO; Berwick M; Verschraegen CF; Wiggins C; Lansing L; Muller CY; Qualls CR
Obstet Gynecol; 2006 May; 107(5):1075-85. PubMed ID: 16648414
[TBL] [Abstract][Full Text] [Related]
17. Malignant ovarian germ cell tumor - role of surgical staging and gonadal dysgenesis.
Lin KY; Bryant S; Miller DS; Kehoe SM; Richardson DL; Lea JS
Gynecol Oncol; 2014 Jul; 134(1):84-9. PubMed ID: 24836278
[TBL] [Abstract][Full Text] [Related]
18. MALIGNANT OVARIAN GERM CELL TUMORS AT A TERTIARY CARE SETTING IN PAKISTAN.
Hannan A; Malik MA; Fasih S; Badar F; Siddiqui N
J Ayub Med Coll Abbottabad; 2015; 27(3):624-7. PubMed ID: 26721024
[TBL] [Abstract][Full Text] [Related]
19. Is Omentectomy Mandatory Among Early Stage (I, II) Malignant Ovarian Germ Cell Tumor Patients? A Retrospective Study of 223 Cases.
Xu W; Li Y
Int J Gynecol Cancer; 2017 Sep; 27(7):1373-1378. PubMed ID: 28520571
[TBL] [Abstract][Full Text] [Related]
20. Regional deep hyperthermia for salvage treatment of children and adolescents with refractory or recurrent non-testicular malignant germ-cell tumours: an open-label, non-randomised, single-institution, phase 2 study.
Wessalowski R; Schneider DT; Mils O; Friemann V; Kyrillopoulou O; Schaper J; Matuschek C; Rothe K; Leuschner I; Willers R; Schönberger S; Göbel U; Calaminus G;
Lancet Oncol; 2013 Aug; 14(9):843-52. PubMed ID: 23823158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
